Services

We help biotech and translational teams reduce costly preclinical-to-IND mistakes with independent review and clear deliverables. Fixed-scope, asynchronous options—no long sales cycle.

48-hour Protocol Triage Memo

Light-touch written triage: top risks and next-step options within 48 hours of doc receipt. Buy now, no call required. We request docs securely after payment.

Buy now

1–2 week Sprint Review

Full independent review of your protocol and PK/PD dosing plan. Written summary, actionable recommendations, regulatory and CRO-readiness. Book a call to scope.

Book a call

CRO-Readiness Review

Ensure your CRO-facing protocols, timelines, and data expectations are clear and aligned. Reduce rework and miscommunication.

Book a Call

DDQ Memo

Due diligence support for investors: concise memo on protocol and PK/PD risk for a given program or asset.